StockData
Evommune, Inc. logo

Evommune, Inc. (EVMN) income statement

EVMNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30
$7.24+0.36 (+5.23%)

Close on Nov 19, 2026Market cap $262.76MP/E –Yield –

See a number that looks wrong?